Yes — Stemline Therapeutics has a documented H-1B filing history: official US Department of Labor disclosure data lists 2 H-1B labor condition application (LCA) records for this employer. The most recent imported disclosure period is FY2026 Q3.
An LCA is the labor-condition step an employer must file with DOL before USCIS can approve an H-1B petition, so these rows are documented sponsorship activity — not a promise that Stemline Therapeutics will sponsor a new hire, and not evidence that any petition was approved. USCIS decides each petition separately. Verified against official DOL OFLC disclosure data on 2026-08-09.
Green-card signal
Does Stemline Therapeutics file PERM green-card cases?
Not in this dataset — official DOL disclosure data lists no PERM (green-card) records for Stemline Therapeutics, though it does list 2 H-1B labor condition application (LCA) records. The most recent imported disclosure period is FY2026 Q3.
H-1B filing activity without PERM rows is common and is not evidence that Stemline Therapeutics refuses to sponsor green cards: PERM cases are published on their own disclosure calendar, are often filed years after the first H-1B, and appear under whichever legal entity files them. Treat missing PERM rows as an absence of evidence for the imported source periods, not as evidence of absence. Verified against official DOL OFLC PERM disclosure data on 2026-08-09.
Summary
Plain-language read
Stemline Therapeutics shows limited recent official filing activity in FY2026 Q3: 2 LCA records and 0 PERM records in the loaded dataset. The most visible roles are Associate Director, Data Strategy & Omnichannel Enablement, Sr. Manager, AI Engineer, with worksites concentrated in Bridgewater, NJ. The observed median wage is $173,772 where annual wage data is available. LCA certification is not USCIS H-1B petition approval, and PERM certification is not green card approval.
Wondering whether Stemline Therapeutics sponsors H-1B? The H-1B sponsor checker reads any company against the same official LCA and PERM filing signals shown here.
Stemline Therapeutics H-1B and PERM research checkpoints
Use this section for searches such as "Stemline Therapeutics H-1B", "Stemline Therapeutics LCA", and "Stemline Therapeutics PERM" before comparing individual case rows.
Activity mix
2 LCA rows and 0 PERM rows are normalized to this employer.
Name matching is a normalization heuristic. Read the source methodology and import freshness before treating matched aliases as a complete sponsor history.
Filing trends
Stemline Therapeutics filing volume
2 imported H-1B/LCA and PERM filings · median wage $173,772Too few records for a fiscal-year trend chart — see the case tabs for full rows.
Roles
Top official job titles
Associate Director, Data Strategy & Omnichannel Enablement1
Sr. Manager, AI Engineer1
Worksites
Top locations
Bridgewater, NJ2
Status mix
Case statuses
Certified2
Related sponsors
Sponsors adjacent to Stemline Therapeutics
Employers with imported DOL LCA or PERM filings that also list New Jersey worksites, weighted toward overlapping roles. Shared filing footprints are a research and discovery signal, not a hiring or sponsorship guarantee.
LCA and PERM rows are filing signals, not USCIS approvals, green-card approvals, legal advice, or outcome predictions.
FAQ
Common questions
Does Stemline Therapeutics sponsor H-1B workers?
Yes — Stemline Therapeutics has a documented H-1B filing history: official US Department of Labor disclosure data lists 2 H-1B labor condition application (LCA) records for this employer. The most recent imported disclosure period is FY2026 Q3. An LCA is the labor-condition step an employer must file with DOL before USCIS can approve an H-1B petition, so these rows are documented sponsorship activity — not a promise that Stemline Therapeutics will sponsor a new hire, and not evidence that any petition was approved. USCIS decides each petition separately. Verified against official DOL OFLC disclosure data on 2026-08-09.
Does Stemline Therapeutics file PERM green-card cases?
Not in this dataset — official DOL disclosure data lists no PERM (green-card) records for Stemline Therapeutics, though it does list 2 H-1B labor condition application (LCA) records. The most recent imported disclosure period is FY2026 Q3. H-1B filing activity without PERM rows is common and is not evidence that Stemline Therapeutics refuses to sponsor green cards: PERM cases are published on their own disclosure calendar, are often filed years after the first H-1B, and appear under whichever legal entity files them. Treat missing PERM rows as an absence of evidence for the imported source periods, not as evidence of absence. Verified against official DOL OFLC PERM disclosure data on 2026-08-09.
What does VisaSignal show for Stemline Therapeutics H-1B and PERM?
For Stemline Therapeutics H-1B research, the page summarizes imported DOL LCA labor-condition rows. For Stemline Therapeutics PERM research, it summarizes imported DOL permanent labor certification rows. Both include roles, worksites, wage signals, case-status mix, and the latest source period.
Does an LCA certification mean an H-1B petition was approved?
No. A DOL-certified LCA is not the same as USCIS H-1B petition approval. It is an official labor-condition filing signal that should be interpreted with that limit.
Does a PERM certification mean a green card was approved?
No. PERM certification is one step in an employment-based green card process. It does not mean a green card, I-140 petition, or adjustment of status was approved.
Can this data prove an employer will sponsor a candidate?
No. Official filing history can show recent activity, roles, worksites, and wage signals, but it does not guarantee future sponsorship or predict legal outcomes.